Skip to main content


  • Wednesday, Jun 10th
    4:00 PM - 4:15 PM PST
    Discovery of Autoimmune T cell Antigens Through Transsynaptic Lymphocyte Adhesion Biosensing
    Presenting Author: Josiah K. Gerdts, MD PhD – University of California San Francisco
    Autoimmune Diseases
  • Wednesday, Jun 10th
    4:00 PM - 4:15 PM PST
    Loss of Tolerance to Perilipin-1 in a Mouse Model of Adipose Autoimmunity
    Presenting Author: Irina Proekt, PhD – University of California San Francisco
    Autoimmune Diseases
  • Wednesday, Jun 10th
    4:15 PM - 4:30 PM PST
    Dynamics of Peripheral Helper T (Tph) cells Across Multiple Joints and Circulation in Rheumatoid Arthritis
    Presenting Author: Osamu Iri, MD – Kyoto University, Graduate School of Medicine
    Autoimmune Diseases
  • Wednesday, Jun 10th
    4:45 PM - 5:00 PM PST
    Early Detection and Monitoring of Type 1 Diabetes Using a Shared T Cell Receptor Signature
    Presenting Author: Rebecca Elyanow, PhD – Adaptive Biotechnologies
    Autoimmune Diseases
  • Wednesday, Jun 10th
    5:00 PM - 5:15 PM PST
    A Surviving Beta Cell Subpopulation Enriched in Patients with Type 1 Diabetes
    Presenting Author: Maxwell Spurrell, n/a – Yale School of Medicine
    Autoimmune Diseases
  • Wednesday, Jun 10th
    5:00 PM - 5:15 PM PST
    Lesional and Perilesional Tissue Comparisons Across Immune-Mediated Inflammatory Diseases Reveal Disease-Specific Immunoregulatory Mechanisms Mediated by Peripheral Helper and Regulatory T Cells
    Presenting Author: Anthony K. McLean, BSc MRes MRSB – Newcastle University
    Autoimmune Diseases
  • Wednesday, Jun 10th
    5:15 PM - 5:30 PM PST
    PD-L1 on Pancreatic Beta Cells Synergizes with Tregs to Maintain Islet-specific CD8 T Cell Tolerance in Non-autoimmune Settings
    Presenting Author: Jiaming He, n/a – Yale University
    Autoimmune Diseases
  • Wednesday, Jun 10th
    5:30 PM - 5:45 PM PST
    Immune Checkpoint Activation Targeting PD-1H (VISTA) Reinforces Human T-Cell Tolerance in Autoimmunity
    Presenting Author: Xue Han, PhD – The Ohio State University
    Autoimmune Diseases
  • Thursday, Jun 11th
    10:25 AM - 10:40 AM PST
    Accelerated Identification and Validation of Therapeutic Targets for Systemic Lupus Erythematosus
    Presenting Author: Xiaoguang Li, MD, PhD – AbbVie
    Autoimmune Diseases
  • Thursday, Jun 11th
    11:05 AM - 11:20 AM PST
    First Oral Small-Molecule Inhibitors Designed by Generative AI Achieve Biologics-Like Pan-Inhibition of IL-17AA, AF, and FF Dimers
    Presenting Author: Chris Li, Ph.D. – Anew Therapeutics
    Autoimmune Diseases
  • Thursday, Jun 11th
    4:00 PM - 4:15 PM PST
    Epstein-Barr Virus Reprograms Autoreactive B cells as Antigen-presenting Cells in Autoimmune Diseases
    Presenting Author: Shady Younis, PhD – STANFORD UNIVERSITY
    Autoimmune Diseases
  • Thursday, Jun 11th
    4:30 PM - 4:45 PM PST
    Defining the Immunological Features of CD19 CAR T cell Therapy in MRL/lpr Mice
    Presenting Author: Tatiana Lau, n/a – University of British Columbia
    Autoimmune Diseases
  • Thursday, Jun 11th
    5:00 PM - 5:15 PM PST
    CNP-104, an Antigen-Specific Tolerogenic Nanoparticle Therapy, Stabilizes Prognostic Trajectory and Liver Stiffness with a Link to Reduction in Pathogenic T-Cells in Primary Biliary Cholangitis
    Presenting Author: Adam Elhofy, PhD – COUR Pharma
    Autoimmune Diseases
  • Thursday, Jun 11th
    5:45 PM - 6:00 PM PST
    From Tolerance to Pathogenesis: Exploring the BND1 to BND2 B cell Developmental Pathway in T1D
    Presenting Author: Brandon Hilliard, BA – CU Anschutz
    Autoimmune Diseases